You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 維亞生物(1873.HK)逆勢漲5% 機構稱未來3-5年業績將呈現高速增長
格隆匯 07-08 15:47
格隆匯7月8日丨維亞生物(1873.HK)逆勢拉昇漲5%,連續錄得2日反彈。現報9.58港元,成交額超2億港元,總市值185億港元。華西證券發佈研究報吿稱,維亞生物作為全球領先的藥物發現+CDMO業務提供商,且創新性的基於公司領先的藥物發現技術平台為全球Biotech企業進行賦能同時分享其創新紅利,未來3-5年公司業績將呈現高速增長。該行維持公司“買入”評級。另外,公司未來戰略投資以及EFS 模式確認規模持續增長,以及孵化公司的在研項目持續推進,公司將能從EFS 業務獲得相對穩定的現金流入、分享全球創新紅利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account